DCF — MEDICAL CITY NORTH HILLS
Enterprise Value: $109.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$109.1M
Enterprise Value
$27.8M
PV of Cash Flows
$81.4M
PV of Terminal Value
$131.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $176.4M | $15.0M | 8.0% | $4.9M | $4.4M |
| Year 2 | $181.7M | $17.3M | 9.0% | $6.4M | $5.3M |
| Year 3 | $187.1M | $19.6M | 10.0% | $8.0M | $6.0M |
| Year 4 | $192.8M | $21.2M | 11.0% | $8.9M | $6.1M |
| Year 5 | $198.5M | $22.3M | 11.0% | $9.6M | $6.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $109.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$171.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0799999974308046
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5